Identifi cation of prostamides, fatty acyl ethanolamines, and their biosynthetic precursors in rabbit cornea

Journal of Lipid Research

Volumn 56, Issue 8, 2015, Pages 1419-1433

  Urquhart, Paula ^a   Wang, Jenny ^b   Woodward, David F ^b   Nicolaou, Anna ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ALLERGAN INC   (United States)

Author keywords

Anandamide; Cyclooxygenase; Fatty acid amide hydrolase; Liquid chromatography tandem mass spectrometry; N acyl phosphatidylethanolamine; Nacyl phosphatidylethanolamine phospholipase D; Ocular tissue; Prostaglandin; Prostaglandin ethanolamine; Prostaglandin synthase

Indexed keywords

ALPHA LINOLENOYL DOCOSAHEXAENOYL ETHANOLAMINE; ANANDAMIDE; ARACHIDONIC ACID; ETHANOLAMINE; FATTY ACYL ETHANOLAMINE; GAMMA LINOLENIC ACID; LINOLENOYL ETHANOLAMINE; OLEOYL ETHANOLAMINE; PALMITOYL ETHANOLAMINE; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; PROSTAMIDE; STEAROYL ETHANOLAMINE; UNCLASSIFIED DRUG; ETHANOLAMINE DERIVATIVE;

AQUEOUS HUMOR; ARTICLE; CELLULAR DISTRIBUTION; CORNEA; ELECTROSPRAY MASS SPECTROMETRY; ENZYME METABOLISM; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; HYDROLYSIS; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; METABOLISM; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; CHEMISTRY; RABBIT;

ANIMALS; CORNEA; DINOPROSTONE; ETHANOLAMINES; RABBITS;

EID: 84941264218     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M055772     Document Type: Article

References (61)

1. Srinivas, S. P. 2010. Dynamic regulation of barrier integrity of the corneal endothelium. Optom. Vis. Sci. 87 : E239-E254.
2. Maddula, S., D. K. Davis, M. K. Burrow, and B. K. Ambati. 2011. Horizons in therapy for corneal angiogenesis. Ophthalmology. 118 : 591-599.
3. Cursiefen, C. 2007. Immune privilege and angiogenic privilege of the cornea. Chem. Immunol. Allergy. 92 : 50-57.
4. Chen, K. H., W. M. Hsu, C. C. Chiang, and Y. S. Li. 2003. Transforming growth factor-beta2 inhibition of corneal endothelial proliferation mediated by prostaglandin. Curr. Eye Res. 26 : 363-370.
5. Daniel, T. O., H. Liu, J. D. Morrow, B. C. Crews, and L. J. Marnett. 1999. Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res. 59 : 4574-4577.
6. Black, A. T., M. K. Gordon, D. E. Heck, M. A. Gallo, D. L. Laskin, and J. D. Laskin. 2011. UVB light regulates expression of antioxidants and infl ammatory mediators in human corneal epithelial cells. Biochem. Pharmacol. 81 : 873-880.
7. Liclican, E. L., V. Nguyen, A. B. Sullivan, and K. Gronert. 2010. Selective activation of the prostaglandin E2 circuit in chronic injury-induced pathologic angiogenesis. Invest. Ophthalmol. Vis. Sci. 51 : 6311-6320.
8. Murata, T., M. I. Lin, K. Aritake, S. Matsumoto, S. Narumiya, H. Ozaki, Y. Urade, M. Hori, and W. C. Sessa. 2008. Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo. Proc. Natl. Acad. Sci. USA. 105,2008,20009-20014
9. Woodward, D. F., A. H. Krauss, J. Chen, Y. Liang, C. Li, C. E. Protzman, A. Bogardus, R. Chen, K. M. Kedzie, H. A. Krauss, et al. 2003. Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024). J. Pharmacol. Exp. Ther. 305,772-785
10. Yu, M., D. Ives, and C. S. Ramesha. 1997. Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. J. Biol. Chem. 272,21181-21186
11. Kozak, K. R., B. C. Crews, J. D. Morrow, L. H. Wang, Y. H. Ma, R. Weinander, P. J. Jakobsson, and L. J. Marnett. 2002. Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J. Biol. Chem. 277 : 44877-44885.
12. Koda, N., Y. Tsutsui, H. Niwa, S. Ito, D. F. Woodward, and K. Watanabe. 2004. Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identifi cation of Bimatoprost as a potent inhibitor of the enzyme: new enzyme assay method using LC/ ESI/MS. Arch. Biochem. Biophys. 424 : 128-136.
13. Yang, W., J. Ni, D. F. Woodward, D. D. Tang-Liu, and K. H. Ling. 2005. Enzymatic formation of prostamide F2alpha from anandamide involves a newly identifi ed intermediate metabolite, prostamide H2. J. Lipid Res. 46 : 2745-2751.
14. Ueda, N., K. Tsuboi, and T. Uyama. 2013. Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways. FEBS J. 280 : 1874-1894.
15. Liu, J., L. Wang, J. Harvey-White, B. X. Huang, H. Y. Kim, S. Luquet, R. D. Palmiter, G. Krystal, R. Rai, A. Mahadevan, et al. 2008. Multiple pathways involved in the biosynthesis of anandamide. Neuropharmacology. 54 : 1-7.
16. Cravatt, B. F., D. K. Giang, S. P. Mayfi eld, D. L. Boger, R. A. Lerner, and N. B. Gilula. 1996. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature. 384 : 83-87.
17. Tsuboi, K., N. Takezaki, and N. Ueda. 2007. The N-acylethanolaminehydrolyzing acid amidase (NAAA). Chem. Biodivers. 4 : 1914-1925.
18. Ritter, J. K., C. Li, M. Xia, J. L. Poklis, A. H. Lichtman, R. A. Abdullah, W. L. Dewey, and P. L. Li. 2012. Production and actions of the anandamide metabolite prostamide E2 in the renal medulla. J. Pharmacol. Exp. Ther. 342 : 770-779.
19. Patsos, H. A., D. J. Hicks, R. R. Dobson, A. Greenhough, N. Woodman, J. D. Lane, A. C. Williams, and C. Paraskeva. 2005. The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2. Gut. 54 : 1741-1750.
20. Andrianova, E. L., E. E. Genrikhs, M. Y. Bobrov, A. A. Lizhin, N. M. Gretskaya, L. E. Frumkina, L. G. Khaspekov, and V. V. Bezuglov. 2011. In vitro effects of anandamide and prostamide e2 on normal and transformed nerve cells. Bull. Exp. Biol. Med. 151 : 30-32.
21. Gatta, L., F. Piscitelli, C. Giordano, S. Boccella, A. Lichtman, S. Maione, and V. Di Marzo. 2012. Discovery of prostamide F2alpha and its role in infl ammatory pain and dorsal horn nociceptive neuron hyperexcitability. PLoS ONE. 7 : e31111.
22. Spada, C. S., A. H. Krauss, D. F. Woodward, J. Chen, C. E. Protzman, A. L. Nieves, L. A. Wheeler, D. F. Scott, and G. Sachs. 2005. Bimatoprost and prostaglandin F(2 alpha) selectively stimulate intracellular calcium signaling in different cat iris sphincter cells. Exp. Eye Res. 80 : 135-145.
23. Woodward, D. F., A. H. Krauss, J. W. Wang, C. E. Protzman, A. L. Nieves, Y. Liang, Y. Donde, R. M. Burk, K. Landsverk, and C. Struble. 2007. Identifi cation of an antagonist that selectively blocks the activity of prostamides (prostaglandin-ethanolamides) in the feline iris. Br. J. Pharmacol. 150 : 342-352.
24. Matias, I., J. Chen, L. De Petrocellis, T. Bisogno, A. Ligresti, F. Fezza, A. H. Krauss, L. Shi, C. E. Protzman, C. Li, et al. 2004. Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism. J. Pharmacol. Exp. Ther. 309 : 745-757.
25. Hernangómez, M., L. Mestre, F. G. Correa, F. Loría, M. Mecha, P. M. Iñigo, F. Docagne, R. O. Williams, J. Borrell, and C. Guaza. 2012. CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced infl ammation. Glia. 60 : 1437-1450.
26. Russo, R., J. Loverme, G. La Rana, T. R. Compton, J. Parrott, A. Duranti, A. Tontini, M. Mor, G. Tarzia, A. Calignano, et al. 2007. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3 ?-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice. J. Pharmacol. Exp. Ther. 322 : 236-242.
27. Pate, D. W., K. Järvinen, A. Urtti, P. Jarho, and T. Järvinen. 1995. Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits. Curr. Eye Res. 14 : 791-797.
28. Luchicchi, A., and M. Pistis. 2012. Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specifi cities of the two major endocannabinoids. Mol. Neurobiol. 46 : 374-392.
29. Coulon, D., L. Faure, M. Salmon, V. Wattelet, and J. J. Bessoule. 2012. Occurrence, biosynthesis and functions of N-acylphosphatidylethanolamines (NAPE): not just precursors of N-acylethanolamines (NAE). Biochimie. 94 : 75-85.
30. Wellner, N., T. A. Diep, C. Janfelt, and H. S. Hansen. 2013. N-acylation of phosphatidylethanolamine and its biological functions in mammals. Biochim. Biophys. Acta. 1831 : 652-662.
31. Ahn, K., D. S. Johnson, M. Mileni, D. Beidler, J. Z. Long, M. K. McKinney, E. Weerapana, N. Sadagopan, M. Liimatta, S. E. Smith, et al. 2009. Discovery and characterization of a highly selective FAAH inhibitor that reduces infl ammatory pain. Chem. Biol. 16 : 411-420.
32. Astarita, G., and D. Piomelli. 2009. Lipidomic analysis of endocannabinoid metabolism in biological samples. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877 : 2755-2767.
33. Kingsley, P. J., and L. J. Marnett. 2009. Analysis of endocannabinoids, their congeners and COX-2 metabolites. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877 : 2746-2754.
34. Masoodi, M., and A. Nicolaou. 2006. Lipidomic analysis of twentyseven prostanoids and isoprostanes by liquid chromatography/ electrospray tandem mass spectrometry. Rapid Commun. Mass Spectrom. 20 : 3023-3029.
35. Masoodi, M., A. A. Mir, N. A. Petasis, C. N. Serhan, and A. Nicolaou. 2008. Simultaneous lipidomic analysis of three families of bioactive lipid mediators leukotrienes, resolvins, protectins and related hydroxy-fatty acids by liquid chromatography/electrospray ionisation tandem mass spectrometry. Rapid Commun. Mass Spectrom. 22 : 75-83.
36. Astarita, G., F. Ahmed, and D. Piomelli. 2008. Identifi cation of biosynthetic precursors for the endocannabinoid anandamide in the rat brain J. Lipid Res. 49 : 48-57
37. Weber, A., J. Ni, K. H. Ling, A. Acheampong, D. D. Tang-Liu, R. Burk, B. F. Cravatt, and D. Woodward. 2004. Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry. J. Lipid Res. 45 : 757-763.
38. Tai, H. H. 2011. Prostaglandin catabolic enzymes as tumor suppressors. Cancer Metastasis Rev. 30 : 409-417.
39. Beermann, C., M. Mobius, N. Winterling, J. J. Schmitt, and G. Boehm. 2005. sn-position determination of phospholipid-linked fatty acids derived from erythrocytes by liquid chromatography electrospray ionization ion-trap mass spectrometry. Lipids. 40 : 211-218.
40. Reddy, P. V., V. Natarajan, P. C. Schmid, and H. H. Schmid. 1983. N-Acylation of dog heart ethanolamine phospholipids by transacylase activity. Biochim. Biophys. Acta. 750 : 472-480.
41. Bisogno, T., I. Delton-Vandenbroucke, A. Milone, M. Lagarde, and V. Di Marzo. 1999. Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina. Arch. Biochem. Biophys. 370 : 300-307.
42. Stinson, A. M., R. D. Wiegand, and R. E. Anderson. 1991. Fatty acid and molecular species compositions of phospholipids and diacylglycerols from rat retinal membranes. Exp. Eye Res. 52 : 213-218.
43. Nakanishi, H., Y. Iida, T. Shimizu, and R. Taguchi. 2010. Separation and quantifi cation of sn-1 and sn-2 fatty acid positional isomers in phosphatidylcholine by RPLC-ESIMS/MS. J. Biochem. 147 : 245-256.
44. Garcia-Ovejero, D., A. Arevalo-Martin, S. Petrosino, F. Docagne, C. Hagen, T. Bisogno, M. Watanabe, C. Guaza, V. Di Marzo, and E. Molina-Holgado. 2009. The endocannabinoid system is modulated in response to spinal cord injury in rats. Neurobiol. Dis. 33 : 57-71.
45. Rani Sagar, D., J. J. Burston, S. G. Woodhams, and V. Chapman. 2012. Dynamic changes to the endocannabinoid system in models of chronic pain. Philos. Trans. R. Soc. Lond. B Biol. Sci. 367 : 3300-3311.
46. Correa, F., M. Hernangomez, L. Mestre, F. Loria, A. Spagnolo, F. Docagne, V. Di Marzo, and C. Guaza. 2010. Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1/2, JNK, and NF-kappaB. Glia. 58 : 135-147.
47. Bereiter, D. A., D. F. Bereiter, and H. Hirata. 2002. Topical cannabinoid agonist, WIN55, 212-2, reduces cornea-evoked trigeminal brainstem activity in the rat. Pain. 99 : 547-556.
48. Yang, H., Z. Wang, J. E. Capo-Aponte, F. Zhang, Z. Pan, and P. S. Reinach. 2010. Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cells. Exp. Eye Res. 91 : 462-471.
49. Pisanti, S., P. Picardi, L. Prota, M. C. Proto, C. Laezza, P. G. McGuire, L. Morbidelli, P. Gazzerro, M. Ziche, A. Das, et al. 2011. Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis. Blood. 117 : 5541-5550.
50. Chen, J., I. Matias, T. Dinh, T. Lu, S. Venezia, A. Nieves, D. F. Woodward, and V. Di Marzo. 2005. Finding of endocannabinoids in human eye tissues: implications for glaucoma. Biochem. Biophys. Res. Commun. 330 : 1062-1067.
51. Petrosino, S., T. Iuvone, and V. Di Marzo. 2010. N-palmitoylethanolamine: biochemistry and new therapeutic opportunities. Biochimie. 92 : 724-727.
52. Esposito, E., and S. Cuzzocrea. 2013. Palmitoylethanolamide is a new possible pharmacological treatment for the infl ammation associated with trauma. Mini Rev. Med. Chem. 13 : 237-255.
53. Thabuis, C., D. Tissot-Favre, J. B. Bezelgues, J. C. Martin, C. Cruz-Hernandez, F. Dionisi, and F. Destaillats. 2008. Biologicalfunctions and metabolism of oleoylethanolamide. Lipids. 43 : 887-894.
54. Bradbury, J. 2011. Docosahexaenoic acid (DHA): an ancient nutrient for the modern human brain. Nutrients. 3 : 529-554.
55. Fowler, C. J. 2012. NSAIDs: eNdocannabinoid stimulating antiinfl ammatory drugs? Trends Pharmacol. Sci. 33 : 468-473.
56. Hermanson, D. J., N. D. Hartley, J. Gamble-George, N. Brown, B. C. Shonesy, P. J. Kingsley, R. J. Colbran, J. Reese, L. J. Marnett, and S. Patel. 2013. Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation. Nat. Neurosci. 16 : 1291-1298.
57. Yang, H. Y., F. Karoum, C. Felder, H. Badger, T. C. Wang, and S. P. Markey. 1999. GC/MS analysis of anandamide and quantifi cation of N-arachidonoylphosphatidylethanolamides in various brain regions, spinal cord, testis, and spleen of the rat. J. Neurochem. 72 : 1959-1968.
58. Deutsch, D. G., M. S. Goligorsky, P. C. Schmid, R. J. Krebsbach, H. H. Schmid, S. K. Das, S. K. Dey, G. Arreaza, C. Thorup, G. Stefano, et al. 1997. Production and physiological actions of anandamide in the vasculature of the rat kidney. J. Clin. Invest. 100 : 1538-1546.
59. Moriuchi, H., N. Koda, E. Okuda-Ashitaka, H. Daiyasu, K. Ogasawara, H. Toh, S. Ito, D. F. Woodward, and K. Watanabe. 2008. Molecular characterization of a novel type of prostamide/ prostaglandin F synthase, belonging to the thioredoxin-like superfamily. J. Biol. Chem. 283 : 792-801.
60. Urade, Y., K. Watanabe, and O. Hayaishi. 1995. Prostaglandin D, E, and F synthases. J. Lipid Mediat. Cell Signal. 12 : 257-273.
61. Kozak, K. R., B. C. Crews, J. L. Ray, H. H. Tai, J. D. Morrow, and L. J. Marnett. 2001. Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo. J. Biol. Chem. 276 : 36993-36998.